in ,

Buzzkill: Many Public Marijuana Companies Have Just Several Months Worth Of Cash Left

U.S. firms are better off than Canadian ones – at least for the time being…  

While the idea of marijuana companies has certainly been a hot topic in the public market space – especially since Tilray’s epic short squeeze in late 2018 – companies in the sector have been silently burning through their war chests of cash, leaving many just months away from being completely out of cash altogether. 

Large Canadian pot producers have a median of just 6.5 months of cash left, according to Bloomberg. This compares to 14.4 months for most U.S. multi-state operators. For operators in both countries, the clock is ticking for them to raise capital and likely cut costs. 

Names like Aurora Cannabis are going to have to address the problem sooner, rather than later. The company has the worst cash position of Canadian producers with just 2.3 months of liquidity remaining. Tilray isn’t far behind, with just 3.7 months of liquidity. 

Aurora announced this week that it was going to be cutting 500 jobs as part of a major cost cutting effort. It also announced that its CEO would be stepping down. Regardless of the changes internally, the reality of the situation is that the company is still going to be in dire need of cash soon.

Another option for cannabis companies that don’t want to go to the market and raise cash is to merge or find a partner in the future. Investors may be more likely to deploy capital to marijuana names under better circumstances than traditional equity raises or bond issues. And there has undoubtedly been an appetite for mergers and acquisitions in the space, with names like Altria taking a $1.8 billion stake in Cronos Group in 2019. 

Hershel Gerson, chief executive officer of Ello Capital, said: “I think people are looking for quality management teams that can effectuate a turnaround and have experience operating in a tighter environment than some of these early C-level teams.”

“There’s a switch going on related to the management teams that is potentially going to benefit the industry going forward,” he concluded. 

The clock is officially ticking and we’ll check back in several months to see just how beneficial these changes really are…

Help us grow. Support The Duran on Patreon!


The statements, views and opinions expressed in this column are solely those of the author and do not necessarily represent those of The Duran.

What do you think?

Notify of
Newest Most Voted
Inline Feedbacks
View all comments
Conor Hanley
Conor Hanley
February 17, 2020


February 18, 2020

The real irony is that almost everyone that opposed legalization opposed it on the basis that HOARDS of people were JUST waiting for it to be legalized, and would then start smoking dope. Of course, this was a ridiculous straw man argument (as both sides knew full well), as the present situation outlined in this post so unequivocally illustrates. So, for those that posited this laughably stupid scenario as the reason why it was so vital to oppose legalization, where did all these buyers that were JUST WAITING for legalization to start smoking dope disappear to? Why aren’t they beating… Read more »

Reply to  oldandjaded
February 18, 2020

Here’s another interesting question. Was does it say about the relative levels of hope and optimism in the US and Canada, and the relative desire of the two populations to avoid their existing realities, that the American based companies are doing ok, and the Canadian ones can barely manage to keep the doors open? What does this say about the opiate crisis in the US, vs its virtual non-existence in Canada?

‘Western doctors overprescribe drugs’ – Jordan Peterson’s daughter Mikhaila tells RT why he went to Russia for treatment

‘No shred of evidence’: Iran demands US presents proof of Saudi oil attacks claim after UN report release